Search Results - "Tarullo, Sarah"

Postpartum breast cancer progression is driven by semaphorin 7a-mediated invasion and survival by Tarullo, Sarah E., Hill, Ryan C., Hansen, Kirk C., Behbod, Fariba, Borges, Virginia F., Nelson, Andrew C., Lyons, Traci R.

“…Young women diagnosed with breast cancer (BC) have poor prognosis due to increased rates of metastasis. In addition, women diagnosed within 10 years of most…”
Get full text

Receptor for hyaluronan‐mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients by Tarullo, Sarah E, He, Yuyu, Daughters, Claire, Knutson, Todd P, Henzler, Christine M, Price, Matthew A, Shanley, Ryan, Witschen, Patrice, Tolg, Cornelia, Kaspar, Rachael E, Hallstrom, Caroline, Gittsovich, Lyubov, Sulciner, Megan L, Zhang, Xihong, Forster, Colleen L, Lange, Carol A, Shats, Oleg, Desler, Michelle, Cowan, Kenneth H, Yee, Douglas, Schwertfeger, Kathryn L, Turley, Eva A, McCarthy, James B, Nelson, Andrew C

“…Breast cancer invasion and metastasis result from a complex interplay between tumor cells and the tumor microenvironment (TME). Key oncogenic changes in the…”
Get full text

Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation by Yang, Jianbo, Liao, Qianjin, Price, Matthew, Moriarity, Branden, Wolf, Natalie, Felices, Martin, Miller, Jeffrey S., Geller, Melissa A., Bendzick, Laura, Hopps, Rachel, Starr, Timothy K., O'Connor, Christine H., Tarullo, Sarah, Nelson, Andrew C., Turley, Eva, Wang, Jing, McCarthy, James B.

“…•Clinical –The studies are the first to identify CSPG4 as an oncoantigen which is associated with poor outcome in patients with ovarian cancer.•CSPG4…”
Get full text

Abstract B54: Investigating semaphorin 7a in hormone receptor-positive breast cancer progression by Crump, Lyndsey, Elder, Alan, Tarullo, Sarah, Franz, Paris, Lyons, Traci

“…While antiestrogen-based treatments are initially effective for hormone receptor-positive (HR+) breast cancer, these tumors often recur, metastasize, and lose…”
Get full text

Abstract 1284: The effect of Semaphorin 7A on breast cancer metastases and chemoresistance in young women by Kines, Kelsey, Tarullo, Sarah, Borges, Virginia, Lyons, Traci

“…Our overall goal is to understand drivers of chemoresistance in triple-negative breast cancer (TNBC) and the mechanisms that contribute to metastatic spread in…”
Get full text

Abstract B55: Investigating the role of semaphorin 7a in triple-negative breast cancer cell invasion by Tarullo, Sarah Elizabeth, Elder, Alan, Hill, Ryan, Hansen, Kirk, Lyons, Traci

“…Despite new targeted therapies and improved screening, breast cancer is the second leading cause of cancer-related death of women in the United States. This…”
Get full text

Semaphorin 7a Drives Breast Cancer Progression Through Intrinsic and Extrinsic Mechanisms by Tarullo, Sarah Elizabeth

“…Breast cancer (BC) remains the second leading cause of cancer-related deaths for women in the US—mainly due to metastatic disease. Additionally, women aged <45…”
Get full text